| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry
|
Chetboun, Mikaël
|
|
|
11 |
6 |
p. 391-401
|
article
|
| 2 |
BETA-2 score at 28 days after islet allogeneic transplantation in type 1 diabetes for predicting 5-year outcomes
|
Forbes, Shareen
|
|
|
11 |
6 |
p. 376-377
|
article
|
| 3 |
BMI versus obesity subtypes in the era of precision medicine
|
Després, Jean-Pierre
|
|
|
11 |
6 |
p. 382-384
|
article
|
| 4 |
Challenging diabetes stigma starts and ends with all of us
|
Speight, Jane
|
|
|
11 |
6 |
p. 380-382
|
article
|
| 5 |
Correction to Lancet Diabetes Endocrinol 2023; 11: 362–74
|
|
|
|
11 |
6 |
p. e8
|
article
|
| 6 |
Effect of COVID-19 restrictions on thyroid cytopathology: delay in the diagnosis of indeterminate lesions
|
Rossi, Esther Diana
|
|
|
11 |
6 |
p. 377-379
|
article
|
| 7 |
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study
|
Medas, Fabio
|
|
|
11 |
6 |
p. 402-413
|
article
|
| 8 |
Implementing digital systems in diabetes care in low-income and middle-income countries: successes and challenges
|
Bahendeka, Silver
|
|
|
11 |
6 |
p. 387-388
|
article
|
| 9 |
Insulin icodec: evolution or revolution in diabetes therapy?
|
Bellary, Srikanth
|
|
|
11 |
6 |
p. 379-380
|
article
|
| 10 |
Maria Fleseriu: driving excellence in pituitary care
|
Burki, Talha
|
|
|
11 |
6 |
p. 389
|
article
|
| 11 |
Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
|
Stefan, Norbert
|
|
|
11 |
6 |
p. 426-440
|
article
|
| 12 |
Schooling and diabetes: not a level playing field
|
The Lancet Diabetes & Endocrinology,
|
|
|
11 |
6 |
p. 375
|
article
|
| 13 |
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
|
Philis-Tsimikas, Athena
|
|
|
11 |
6 |
p. 414-425
|
article
|
| 14 |
The food system: hunger for change
|
Burki, Talha
|
|
|
11 |
6 |
p. 390
|
article
|
| 15 |
The PEN-Plus Partnership: addressing severe chronic non-communicable diseases among the poorest billion
|
Bukhman, Gene
|
|
|
11 |
6 |
p. 384-386
|
article
|
Journal description